Aderonke F. Akingbola, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 200 West Esplanade Avenue, Kenner, LA 70065 Phone: 504-464-8588 |
Dr. Virendra Joshi, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 200 W Esplanade Ave, Kenner, LA 70065 Phone: 504-842-4015 Fax: 504-988-8886 |
Dr. Daniel Lawrence Raines, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 200 W Esplanade Ave, Ste 200, Kenner, LA 70065 Phone: 504-464-8500 Fax: 504-464-8525 |
John Neville Harrington Jr., MD Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 200 W Esplanade Ave, Ste 210, Kenner, LA 70065 Phone: 504-842-8546 |
Christopher Nissen Barrilleaux, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 200 W Esplanade Ave, Ste 210, Kenner, LA 70065 Phone: 504-842-8546 Fax: 504-464-8586 |
News Archive
Planning and operational management teams from medical schools, university affiliated hospitals, and academic health science centers across the country will meet at Tradeline's 4th Annual Academic Medical & Health Science Centers Conference November 15-16th at the Hyatt Regency in Scottsdale, Arizona, to chart out strategies for the changing health care model. A special pre-conference tour of the new Phoenix Biomedical Campus, including a unique demonstration of telemedicine, will be conducted on November 14th.
An intranasal influenza vaccine proved to be more effective than the injectable influenza vaccine in children older than 6 months and younger than 5 years of age, according to study data presented at the annual meeting of the Pediatric Academic Societies in San Francisco.
Chinese scientists recently developed a flexible electronic skin (e-skin) capable of self-powered neural stimulation and inducing a neural response. The technology will be useful in characterizing synaptic plasticity.
Mature results from a landmark Phase-III trial have confirmed that patients with EGFR mutation-positive advanced non-small cell lung cancer have better overall survival when treated with gefitinib or chemotherapy than patients whose tumors do not carry such mutations.
› Verified 4 days ago